Search | Page 7 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Allogeneic Stem Cell Transplant With Alpha/Beta T AND B Cell Depletion for Hematologic Malignancies (AB-CliniMACs)

    ... is a single arm pilot study for patients using α/β T cell -depleted PSCT in with alternative donor sources with hematologic ... or partially matched related) mobilized peripheral stem cells (PSCs) using the CliniMACS system for T cell depletion plus ...

    Clinical Trial last updated 06/06/2016 - 3:10pm.

  2. Allogeneic Stem Cell Transplant With Alpha/Beta T AND B Cell Depletion for Hematologic Malignancies (AB-CliniMACs)

    ... is a single arm pilot study for patients using α/β T cell -depleted PSCT in with alternative donor sources with hematologic ... or partially matched related) mobilized peripheral stem cells (PSCs) using the CliniMACS system for T cell depletion plus ...

    Clinical Trial last updated 06/03/2016 - 2:45pm.

  3. MEDALIST Trial

    ... ≤ 20%, or serum ferritin ≤ 15 μg/L  Prior allogeneic or autologous stem cell transplant Known history of diagnosis of Acute myeloid ...

    Clinical Trial last updated 02/22/2017 - 11:42am.

  4. Pregnancy in Bone Marrow Failure Disease

    ... to people without them. But in people who have had an allogeneic stem cell/ bone marrow transplant , the immunosuppressive medications may ...

    Interview last updated 01/13/2017 - 9:28am.

  5. Preventing Stem Cell Transplant Complications With a Blood Separator Machine

    ... Background: - Researchers are working to make stem cell transplant procedures safer and more effective. One complication ... hematologic conditions meeting a standard indication for allogeneic stem cell transplant : 5.1.2.1 Chronic myelogenous leukemia ...

    Clinical Trial last updated 05/23/2016 - 10:57am.

  6. Maintenance Low Dose 5'-Azacitidine Post T Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Myelodysplastic Syndrome and Acute Myelogenous Leukemia With High Risk for Post-Transplant Relapse

    ... to lower the risk of the disease coming back after a stem cell transplant in patients with MDS and AML. This study will also be ... start taking the study drug between days 60-120 post TCD allogeneic hematopoietic stem cell transplant and up to a year post-transplant ...

    Clinical Trial last updated 04/27/2016 - 1:19pm.

  7. Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

    ... Purpose:  Allogeneic hematopoietic stem cell transplantation (aHSCT) can cure patients with a variety of bone ...

    Clinical Trial last updated 04/28/2016 - 2:40pm.

  8. Transplantation

     

    Page last updated 01/20/2015 - 4:45pm.

  9. Organ-Sparing Marrow-Targeted Irradiation Before Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies

    ... Total body irradiation (TBI)-based conditioning prior to allogeneic stem cell transplant . The target patient populations are those with ALL, ...

    Clinical Trial last updated 05/03/2016 - 11:29am.

  10. Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

    ... Purpose:  Allogeneic hematopoietic stem cell transplantation (aHSCT) can cure patients with a variety of bone ...

    Clinical Trial last updated 04/25/2016 - 10:08am.